Company Profile For Galenica AG

Galenica AG (GALN.S) (Swiss Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  27 Nov 2009
361.00CHF
Price Change
+3.00
Percent Change
+0.84%
 
 
Research a stock:   symbol lookup

Overview

Galenica AG is a Switzerland-based company. It focuses on two strategic areas: Specialty Pharma, operating mainly in the anemia, nephrology and consumer health areas, and Swiss HealthCare Services, combining products from the Pharma business sector, logistics services and information management. The Company divides its operations into four business sectors: Vifor Pharma, Logistics, HealthCare Information and Retail. The Vifor Pharma sector develops, produces and markets its Consumer Healthcare products worldwide. The Logistics sector provides integrated services and develops new services for health care logistics throughout Switzerland, and operates through Alloga Ltd, Galexis Ltd and G-Pharma Ltd, among others. The HealthCare Information sector operates through Documed Ltd, e-mediat Ltd, e-prica Ltd and Triamun Ltd, offering data management products. The Retail sector is mainly active through GaleniCare, operating a pharmacy network in Switzerland.

Quick Financial Synopsis

BRIEF: For the six months ended 30 June 2009, Galenica AG's total revenue increased 2% to SF1.57B. Net income for the period increased 11% to SF115.7M. Total revenue reflects an increase in demand for the Company's products and services in Switzerland and Americas geographic segments as well as in Pharma and Logistics business segments. Net income for the period benefited from increased operating margins as well as lower financial expenses.

Company Address

Galenica AG
Untermattweg 8
Berne     3001
P: +4158.8528111
F: +4158.8528112

Total Employees

3538

Find Out More About GALN.S

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement